NO20032393L - Ekspresjonsanalyse av inhibitor av differensiering av nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft - Google Patents
Ekspresjonsanalyse av inhibitor av differensiering av nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreftInfo
- Publication number
- NO20032393L NO20032393L NO20032393A NO20032393A NO20032393L NO 20032393 L NO20032393 L NO 20032393L NO 20032393 A NO20032393 A NO 20032393A NO 20032393 A NO20032393 A NO 20032393A NO 20032393 L NO20032393 L NO 20032393L
- Authority
- NO
- Norway
- Prior art keywords
- differentiation
- diagnosis
- inhibitor
- treatment
- nucleic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25337400P | 2000-11-28 | 2000-11-28 | |
| PCT/US2001/044495 WO2002044417A2 (en) | 2000-11-28 | 2001-11-28 | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20032393D0 NO20032393D0 (no) | 2003-05-27 |
| NO20032393L true NO20032393L (no) | 2003-07-03 |
Family
ID=22959998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20032393A NO20032393L (no) | 2000-11-28 | 2003-05-27 | Ekspresjonsanalyse av inhibitor av differensiering av nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20020182614A1 (no) |
| EP (1) | EP1356107A2 (no) |
| JP (1) | JP2004526424A (no) |
| AU (1) | AU2002239363A1 (no) |
| BR (1) | BR0115689A (no) |
| CA (1) | CA2429721A1 (no) |
| HU (1) | HUP0303890A3 (no) |
| IL (1) | IL155953A0 (no) |
| MX (1) | MXPA03004577A (no) |
| NO (1) | NO20032393L (no) |
| NZ (1) | NZ526706A (no) |
| PL (1) | PL365794A1 (no) |
| WO (1) | WO2002044417A2 (no) |
| ZA (1) | ZA200304997B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2422320A1 (en) * | 2000-09-14 | 2002-03-21 | The Regents Of The University Of California | Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
| AU2003298689A1 (en) * | 2002-11-21 | 2004-06-18 | Wyeth | Methods for diagnosing rcc and other solid tumors |
| US7643943B2 (en) | 2003-02-11 | 2010-01-05 | Wyeth Llc | Methods for monitoring drug activities in vivo |
| US20060194211A1 (en) * | 2003-04-29 | 2006-08-31 | Burczynski Michael E | Methods for prognosis and treatment of solid tumors |
| KR101141951B1 (ko) * | 2003-09-05 | 2012-05-04 | 테리온 바이오로직스, 인크. | 흑색종용 다중-항원 벡터 |
| BRPI0709176A2 (pt) | 2006-03-24 | 2011-06-28 | Phenomenome Discoveries Inc | biomarcadores úteis para diagnosticar o cáncer de próstata e seus métodos |
| KR20220126661A (ko) * | 2021-03-08 | 2022-09-16 | (주)아큐레시스바이오 | 췌장암의 진단용 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6591396A (en) * | 1995-08-01 | 1997-02-26 | Sloan-Kettering Institute For Cancer Research | Id as a diagnostic marker in tumor cells |
| AU2024799A (en) * | 1998-01-09 | 1999-07-26 | President And Fellows Of Harvard College | Immortalization of primary human keratinocytes by the helix-loop-helix protein, id-1 |
| EP1047793B1 (en) * | 1998-01-21 | 2006-11-15 | Dianon Systems, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| CA2422320A1 (en) * | 2000-09-14 | 2002-03-21 | The Regents Of The University Of California | Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
-
2001
- 2001-11-28 NZ NZ526706A patent/NZ526706A/en unknown
- 2001-11-28 MX MXPA03004577A patent/MXPA03004577A/es unknown
- 2001-11-28 CA CA002429721A patent/CA2429721A1/en not_active Abandoned
- 2001-11-28 JP JP2002546765A patent/JP2004526424A/ja active Pending
- 2001-11-28 BR BR0115689-6A patent/BR0115689A/pt not_active IP Right Cessation
- 2001-11-28 PL PL01365794A patent/PL365794A1/xx not_active Application Discontinuation
- 2001-11-28 AU AU2002239363A patent/AU2002239363A1/en not_active Abandoned
- 2001-11-28 WO PCT/US2001/044495 patent/WO2002044417A2/en not_active Application Discontinuation
- 2001-11-28 US US09/996,529 patent/US20020182614A1/en not_active Abandoned
- 2001-11-28 EP EP01987116A patent/EP1356107A2/en not_active Withdrawn
- 2001-11-28 IL IL15595301A patent/IL155953A0/xx unknown
- 2001-11-28 HU HU0303890A patent/HUP0303890A3/hu unknown
-
2003
- 2003-05-27 NO NO20032393A patent/NO20032393L/no unknown
- 2003-06-26 ZA ZA200304997A patent/ZA200304997B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20020182614A1 (en) | 2002-12-05 |
| HUP0303890A3 (en) | 2006-03-28 |
| CA2429721A1 (en) | 2002-06-06 |
| AU2002239363A1 (en) | 2002-06-11 |
| JP2004526424A (ja) | 2004-09-02 |
| MXPA03004577A (es) | 2003-09-04 |
| IL155953A0 (en) | 2003-12-23 |
| BR0115689A (pt) | 2004-02-10 |
| EP1356107A2 (en) | 2003-10-29 |
| PL365794A1 (en) | 2005-01-10 |
| HUP0303890A2 (hu) | 2004-03-01 |
| ZA200304997B (en) | 2004-09-27 |
| WO2002044417A9 (en) | 2003-11-20 |
| NO20032393D0 (no) | 2003-05-27 |
| WO2002044417A3 (en) | 2003-07-24 |
| WO2002044417A2 (en) | 2002-06-06 |
| NZ526706A (en) | 2005-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20032395L (no) | Ekspresjonsanalyse av FKBP-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft | |
| EP1576104A4 (en) | NUCLEIC ACIDS AND CORRESPONDING PROTEINS, NAMED 202P5A5, USEFUL FOR THE TREATMENT AND DETECTION OF CANCER | |
| ITMI20011987A0 (it) | Procedimento e sistema basati su computer per l'analisi di misurazione di manufatti | |
| NO20010196L (no) | Sammensetninger og fremgangsmÕter for terapi og diagnose av prostatakreft | |
| AU6502199A (en) | Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
| EP1622571A4 (en) | NUCLEIC ACIDS AND CORRESPONDING PROTEINS CURED 109P1D4 USEFUL IN THE TREATMENT AND DETECTION OF CANCER | |
| DE60213890D1 (de) | Reaktiver Sondenchip und Fluoreszenz-Detektionssystem | |
| ITTO20001156A0 (it) | Apparecchiatura per il trattamento di disgregazione di campioni biologici e dispositivo disgregatore per l'impiego in detta apparecchiatura. | |
| NO20032393L (no) | Ekspresjonsanalyse av inhibitor av differensiering av nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft | |
| EP1590437A4 (en) | NUCLEIC ACIDS SUITABLE FOR THE TREATMENT AND DETECTION OF CANCER AND CORRESPONDING PROTEINS NAMED 254P1D6B | |
| NO20032391D0 (no) | Ekspresjonsanalyse av KIAA-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft | |
| EP1372719A4 (en) | NUCLEIC ACID AND CORRESPONDING PROTEIN WITH THE NAME 125P5C8 FOR THE TREATMENT AND DETECTION OF CANCER | |
| NO20020207L (no) | Biologiske materialer og fremgangsmåter som er nyttige ved diagnostisering og behandling av sykdom | |
| NO20032394L (no) | Ekspresjonsanalyse av SMARC-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft | |
| EP1409710A4 (en) | NUCLEIC ACID AND CORRESPONDING PROTEIN, DESIGNATED BY 161P5C5, FOR THE TREATMENT AND DETECTION OF CANCER | |
| DE50108075D1 (de) | Anordnung zur visuellen und quantitativen 3-D-Untersuchung von Proben | |
| EP1539805A4 (en) | NUCLEIC ACIDS AND CORRESPONDING PROTEINS SAID 101P3A11 OR PHOR-1 FOR THE TREATMENT AND DETECTION OF CANCERS | |
| EP1399174A4 (en) | NUCLEIC ACID AND RELATED PROTEIN, TREATABLE AND DETECTABLE FOR CANCER, NAME 121P1F1 | |
| EP1499350A4 (en) | NUCLEIC ACID AND ASSOCIATED PROTEIN HAVING NAME 205P1B5 FOR USE IN THE TREATMENT AND DETECTION OF CANCER | |
| GB9906217D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
| GB9917878D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
| ITNA20000012V0 (it) | Macchina di analisi corporea utilizzante misurazione impedenziometrica e ultrasonica. | |
| GB9824091D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
| GB0113011D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
| GB0205963D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases |